Your browser doesn't support javascript.
loading
A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial).
Stürner, Klarissa Hanja; Stellmann, Jan-Patrick; Dörr, Jan; Paul, Friedemann; Friede, Tim; Schammler, Sven; Reinhardt, Stefanie; Gellissen, Susanne; Weissflog, Gainet; Faizy, Tobias Djamsched; Werz, Oliver; Fleischer, Sabine; Vaas, Lea A I; Herrmann, Frank; Pless, Ole; Martin, Roland; Heesen, Christoph.
Afiliación
  • Stürner KH; Institute of Neuroimmunology and Multiple Sclerosis, Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Stellmann JP; Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Dörr J; Department of Neurology, Christian-Albrechts-University, Kiel, Germany.
  • Paul F; Institute of Neuroimmunology and Multiple Sclerosis, Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Friede T; Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Schammler S; NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin and Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Reinhardt S; Clinical and Experimental Multiple Sclerosis Research Center, Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Berlin, Germany.
  • Gellissen S; NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin and Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Weissflog G; Clinical and Experimental Multiple Sclerosis Research Center, Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Berlin, Germany.
  • Faizy TD; Department of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Werz O; Experimental and Clinical Research Center, Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Berlin, Germany.
  • Fleischer S; Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.
  • Vaas LAI; Institute of Neuroimmunology and Multiple Sclerosis, Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Herrmann F; Institute of Neuroimmunology and Multiple Sclerosis, Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Pless O; Institute of Neuroimmunology and Multiple Sclerosis, Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Martin R; Department of Diagnostic and Interventional Neuroradiology, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
  • Heesen C; Institute of Neuroimmunology and Multiple Sclerosis, Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
J Neurol Neurosurg Psychiatry ; 89(4): 330-338, 2018 04.
Article en En | MEDLINE | ID: mdl-29248894
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Olíbano Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurol Neurosurg Psychiatry Año: 2018 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Olíbano Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurol Neurosurg Psychiatry Año: 2018 Tipo del documento: Article País de afiliación: Alemania